These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7402287)

  • 1. Criticism of FDA recommendations for theophylline dosage.
    Murphy JE; Ward ES
    N Engl J Med; 1980 Sep; 303(13):760-1. PubMed ID: 7402287
    [No Abstract]   [Full Text] [Related]  

  • 2. New FDA guidelines for theophylline dosing in infants.
    Murphy JE; Erkan NV; Fakhreddine F
    Clin Pharm; 1986 Jan; 5(1):16. PubMed ID: 3948482
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentially toxic theophylline dose recommendations.
    Hendeles L
    Pediatrics; 1978 Aug; 62(2):275-6. PubMed ID: 693169
    [No Abstract]   [Full Text] [Related]  

  • 4. Concerns about the Food and Drug Administration guidelines for neonatal theophylline dosing.
    Gal P; Gilman JT
    Ther Drug Monit; 1986; 8(1):1-3. PubMed ID: 3961885
    [No Abstract]   [Full Text] [Related]  

  • 5. Revised FDA labeling guideline for theophylline oral dosage forms.
    Hendeles L; Jenkins J; Temple R
    Pharmacotherapy; 1995; 15(4):409-27. PubMed ID: 7479193
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of theophylline in infants.
    FDA Drug Bull; 1985 Aug; 15(2):16-7. PubMed ID: 4054451
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiological health; evaluation of radiation exposure in diagnostic radiology examinations; availability of draft recommendations--FDA. Notice.
    Fed Regist; 1983 Jul; 48(147):34520-1. PubMed ID: 10261489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline, school performance, and the Food and Drug Administration.
    Nicklas RA
    Pediatrics; 1989 Jan; 83(1):146-7. PubMed ID: 2909969
    [No Abstract]   [Full Text] [Related]  

  • 9. New egg safety recommendations added to FDA Food Code.
    J Am Vet Med Assoc; 1999 May; 214(10):1462. PubMed ID: 10340066
    [No Abstract]   [Full Text] [Related]  

  • 10. The once-daily theophylline controversy.
    Barr WH
    Pharmacotherapy; 1984; 4(4):167-8. PubMed ID: 6483636
    [No Abstract]   [Full Text] [Related]  

  • 11. Theophylline is off the OTC market. Ephedrine may be next.
    Chase SL
    RN; 1995 Dec; 58(12):79. PubMed ID: 8560184
    [No Abstract]   [Full Text] [Related]  

  • 12. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of the mutual recognition agreement between the United States and the European Community; pharmaceutical GMP's and medical devices; establishment of a public docket and FDA contact points. Food and Drug Administration, HHS. Establishment of a public docket and FDA contact points.
    Fed Regist; 1999 Mar; 64(45):11376-7. PubMed ID: 10557625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA guidelines on trough: peak ratios in the evaluation of antihypertensive agents. United States Food and Drug Administration.
    Meredith PA; Elliott HL
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S26-30. PubMed ID: 7609502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group makes recommendations to speed FDA device approvals.
    Scott L
    Mod Healthc; 1993 May; 23(19):23. PubMed ID: 10125877
    [No Abstract]   [Full Text] [Related]  

  • 17. Quality assurance in nuclear medicine facilities; availability of final recommendations--FDA. Notice.
    Fed Regist; 1985 May; 50(92):20011-2. PubMed ID: 10271280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recommendations to minimize diagnostic nuclear medicine exposure to the embryo, fetus, and infant; availability of final recommendations--FDA. Notice.
    Fed Regist; 1986 Feb; 51(33):6039. PubMed ID: 10276611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA considers recommendations on mammography quality.
    Randal J
    J Natl Cancer Inst; 2005 Dec; 97(23):1721-2. PubMed ID: 16333026
    [No Abstract]   [Full Text] [Related]  

  • 20. Brief report on the United States Food and Drug Administration Blood Products Advisory Committee recommendations for management of donors and units testing positive for hepatitis B virus DNA.
    Lucey C;
    Vox Sang; 2006 Nov; 91(4):331-5. PubMed ID: 17105609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.